These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inadvertent intrathecal administration of vincristine: has anything changed? Gilbar P J Oncol Pharm Pract; 2012 Mar; 18(1):155-7. PubMed ID: 21965437 [No Abstract] [Full Text] [Related]
3. Drug administration. A fatal error of judgement. Gulland A Nurs Times; 2001 Feb 1-7; 97(5):11. PubMed ID: 11954166 [No Abstract] [Full Text] [Related]
4. Prevent inadvertent administration of intrathecal vincristine. Eisenberg S ONS Connect; 2009 Jan; 24(1):22. PubMed ID: 19253477 [No Abstract] [Full Text] [Related]
10. Medical errors. Appropriate training should avoid accidental intrathecal injection of vincristine. Root T; BMJ; 2001 Jun; 322(7299):1423. PubMed ID: 11417550 [No Abstract] [Full Text] [Related]
11. Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention. Fernandez CV; Esau R; Hamilton D; Fitzsimmons B; Pritchard S J Pediatr Hematol Oncol; 1998; 20(6):587-90. PubMed ID: 9856687 [TBL] [Abstract][Full Text] [Related]
12. Drug administration error related to computerized prescribing. Le Garlantezec P; Aupée O; Alméras D; Lefeuvre L; Souleau B; Sgarioto A; Bohand X J Oncol Pharm Pract; 2010 Dec; 16(4):273-6. PubMed ID: 19833684 [TBL] [Abstract][Full Text] [Related]
13. Introduction of vincristine mini-bags and an assessment of the subsequent risk of extravasation. Nurgat ZA; Smythe M; Al-Jedai A; Ewing S; Rasheed W; Belgaumi A; Ahmed SO; Ashour M; Al Agil A; Siddiqui K; Aljurf M J Oncol Pharm Pract; 2015 Oct; 21(5):339-47. PubMed ID: 24821691 [TBL] [Abstract][Full Text] [Related]
14. Vincristine: right drug, wrong route. Karch AM Am J Nurs; 2006 Jan; 106(1):31-2. PubMed ID: 16481774 [No Abstract] [Full Text] [Related]
15. Coroner 'implores' hospitals to change cancer drug syringe. Nurs Times; 2001 Feb 8-14; 97(6):7. PubMed ID: 11954252 [No Abstract] [Full Text] [Related]
16. Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine? Reddy GK; Brown B; Nanda A Clin Neurol Neurosurg; 2011 Jan; 113(1):68-71. PubMed ID: 20846784 [No Abstract] [Full Text] [Related]
17. Intrathecal vincristine: 3 fatal cases and a review of the literature. Hennipman B; de Vries E; Bökkerink JP; Ball LM; Veerman AJ J Pediatr Hematol Oncol; 2009 Nov; 31(11):816-9. PubMed ID: 19801949 [TBL] [Abstract][Full Text] [Related]
18. Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists. Gilbar P; Chambers CR; Larizza M J Oncol Pharm Pract; 2015 Feb; 21(1):10-8. PubMed ID: 24418800 [TBL] [Abstract][Full Text] [Related]
19. The quest to eliminate intrathecal vincristine errors: a 40-year journey. Noble DJ; Donaldson LJ Qual Saf Health Care; 2010 Aug; 19(4):323-6. PubMed ID: 20211962 [TBL] [Abstract][Full Text] [Related]
20. Appropriateness of maximum-dose guidelines for vincristine. McCune JS; Lindley C Am J Health Syst Pharm; 1997 Aug; 54(15):1755-8. PubMed ID: 9262750 [No Abstract] [Full Text] [Related] [Next] [New Search]